, Singapore

Daily Markets Briefing: STI up 0.6%

Will the index keep its momentum today?

OCBC Investment Research said:

The pull-back on Wall Street overnight is likely to spook the local bourse to a similar retreat this morning.

Despite recovering another 0.6% yesterday, the STI has formed a spinning top candlestick; coupled with the extended rally we have seen in recent days, this suggests that a bearish reversal could be in the makings.

Should the index gap open lower at the open this morning, we could see it sliding further south towards the 3070 resistance-turned-support.

Beyond that, the subsequent base lies at the 3030 support. On the upside, 3120 is now the immediate support-turned-resistance, followed by the next hurdle at the 3150 minor peaks.
 

Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.


If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Top News

AI growth stalls as 78% cite weak data infrastructure
Confluent said firms are prioritising data streaming as they move AI projects from pilots into production.
Singapore emerges as key hub in Asia-Pacific’s next medtech wave
The city-state’s regulatory strength helps translate medical innovations into globally validated products.
Healthcare